Thyroid Cancer Trial, Recruiting (NCT06236373)

Thyroid Cancer Trial, Recruiting NCT06236373 Sponsor: University of Modena and Reggio Emilia Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06236373 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have had breast, prostate, thyroid, colorectal, multiple myeloma, or lymphoma cancer in the past few years, have finished the main phase of treatment, and are now in a monitoring or maintenance phase
You are a carer or family member supporting someone who meets the cancer criteria above, and you are 18 years old or older
You are a stakeholder (such as a healthcare professional or community representative) connected to someone who meets the cancer criteria above, and you are 18 years old or older

Who may not be able to join:

You do not want to take part in the study
You do not speak or understand Italian
You have significant difficulties with thinking, learning, or communication that would make it hard to understand the study, answer interview questions, or take part in a group or individual discussion (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stefania Costi, PhD, Physical Medicine and Rehabilitation Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia

Phone: +393478824741

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06236373

Sponsor: University of Modena and Reggio Emilia

Phase: Not Applicable

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: +393478824741

More information: https://clinicaltrials.gov/study/NCT06236373

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have had breast, prostate, thyroid, colorectal, multiple myeloma, or lymphoma cancer in the past few years, have finished the main phase of treatment, and are now in a monitoring or maintenance phase
You are a carer or family member supporting someone who meets the cancer criteria above, and you are 18 years old or older
You are a stakeholder (such as a healthcare professional or community representative) connected to someone who meets the cancer criteria above, and you are 18 years old or older

Who may not be able to join:

You do not want to take part in the study
You do not speak or understand Italian
You have significant difficulties with thinking, learning, or communication that would make it hard to understand the study, answer interview questions, or take part in a group or individual discussion (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Modena and Reggio Emilia

Registry

ClinicalTrials.gov

Start date

20 April 2023

Est. completion

1 February 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Experience of Self-reported perception of Unmet Needs

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov